Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$337,822,422
+$43,837,492 QoQ
Shares Held
1,342,483
-0.7% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#113
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROYAL LONDON ASSET MANAGEMENT LTD holds $4,029,879,846 across 10 Drug Manufacturers - General names. ABBV ranks #4 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
10,161,026 | $1,926,733,750 | |
| 2 | LLY |
ELI LILLY & Co
|
645,864 | $774,668,722 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,987,037 | $383,834,254 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
1,342,483 | $337,822,422 | |
| 5 | JNJ |
Johnson & Johnson
|
1,189,474 | $302,090,711 | |
| 6 | AMGN |
Amgen Inc
|
280,510 | $101,578,281 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
551,867 | $69,722,876 | |
| 8 | PFE |
Pfizer Inc
|
2,819,076 | $67,883,350 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $337,822,422 | 1,342,483 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $293,984,930 | 1,351,717 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $300,434,189 | 1,314,868 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $302,223,141 | 1,305,274 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $243,915,445 | 1,314,058 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $284,829,659 | 1,359,439 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $231,937,949 | 1,305,222 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $270,801,954 | 1,371,288 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $233,102,540 | 1,359,040 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $267,651,308 | 1,469,804 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $213,059,884 | 1,374,846 | Shares | Sole | 2024-03-01 | |
| 2023-09-30 | $191,005,931 | 1,281,403 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $160,221,185 | 1,189,202 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $158,749,731 | 996,108 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $149,759,300 | 926,671 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $121,746,856 | 907,137 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $146,268,565 | 955,005 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $155,319,374 | 958,111 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $119,757,779 | 884,474 | Shares | Sole | 2022-10-18 | |
| 2021-09-30 | $100,059,025 | 927,589 | Shares | Sole | 2022-10-18 | |
| 2021-06-30 | $106,642,145 | 946,752 | Shares | Sole | 2022-10-18 | |
| 2021-03-31 | $105,339,508 | 973,383 | Shares | Sole | 2022-10-17 | |
| 2020-12-31 | $101,718,887 | 949,313 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $82,913,832 | 946,613 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $91,120,072 | 928,092 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $64,206,760 | 842,719 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||